Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 19, 2000

View Archived Issues

Novartis and Geneva Proteomics establish proteomics alliance

Idec Pharmaceuticals outlines significant Q3 events

IntraDose shows promise in treating liver metastases from colorectal cancer

Maxamine inhibits sarcomas in preclinical study

NIH awards Siga grant for vaccine research

AstraZeneca licenses antiarrhythmic drug candidate from Nortran

Phase III trial reveals potency of H. pylori treatment

IBS treatment launched in Japan by Hokuriku and Fujisawa

Meningococcal C meningitis vaccine approved for very young infants

Status of Dendreon's dendritic cell-based vaccines updated

Antidepressant-like activity observed in validated animal model for NK1 receptor antagonist

AF-2785 and related compounds as potential new male antifertility agents

Nonpeptide Y1 antagonist H-409/22 examined for in vivo effects on vascular responses

NCX-4016 superior to aspirin in reducing myocardial infarct size in animal model

New gelatinase inhibitors suppress endothelial cell proliferation and invasion

First topical treatment for AIDS-related Kaposi's sarcoma approved in E.U.

Cellular experiments suggest potential role for new dimer in prostate cancer therapy

Lorus reports promising phase I/II results with anticancer drug; supply alliance formed

NicOx designs improved antiinflammatory, analgesic and antithrombotic compounds

Preparation, activity and use of new acetylcholinesterase inhibitors reported by Eisai

AHP's new estrogen receptor modulators are useful in bone and cardiovascular diseases

Novel compounds identified at Merck as factor Xa inhibitors

New series of PDE5 inhibitors and their use described by Sanofi-Synthelabo

Elan receives patent coverage for new integrin receptor antagonists

Potent new anti-HIV agents designed at Korean research institute

Ketolides from Abbott endowed with potent antibacterial activity

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...